Occurrence of progressive pulmonary fibrosis and its association with survival in connective tissue disease-associated interstitial lung disease: an international retrospective cohort study

This publication has 36 references indexed in Scilit:

• ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR) Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)
  Annals of the Rheumatic Diseases, 2025
• Epidemiology and Prognosis of Progressive Pulmonary Fibrosis: A Literature Review
  Pulmonary Therapy, 2025
• 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
  Arthritis Care & Research, 2024
• 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
  Arthritis Care & Research, 2024
• Progressive pulmonary fibrosis (PPF): Estimation of incidence and treatment rates in Japan using a claims database
  Respiratory Investigation, 2024
• Interstitial Lung Disease
  JAMA, 2024
• Systemic sclerosis interstitial lung disease: unmet needs and potential solutions
  Nature Reviews Rheumatology, 2023
• Treatment approach to connective tissue disease-associated interstitial lung disease
  Current Opinion in Pharmacology, 2022
• Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities
  The Lancet Respiratory Medicine, 2021
• The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements
  The Lancet Rheumatology, 2020